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Background and the purpose of the study: Several 2, 4-dinitrophenyl and 2,4-dinitrophenylamine tethered 5-FU
(5-fluorouracil) compared to their components have shown minimal or no cytotoxicity to HT-29 cell line under
aerobic conditions but high cytotoxicity and radiosensitizing effects under hypoxic conditions. In the present study
the cytotoxicity and radiation potentiation of three novel analogues of these compounds by replacing 2,4-dinitro-
phenyl moiety with 2-methyl-5-nitroimidazole, a known radiosensitizer and cytotoxic agent was investigated.
Methods: Tethered compounds 7–9 were prepared by the reaction of 1-(t-butoxycarbonyl)-5-fluorouracil 6 with
metronidazole esters 2–4 followed by removal of the t-butoxycarbonyl protecting group. Cytotoxicity of compounds in
HT-29 cells with or without radiation were determined by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT), propidium iodide (PI)-digitonin and clonogenic assays.
Results: Tethered compounds 7–9 induced time-and concentration–dependent cytotoxicity under hypoxia but had
no significant effect under aerobic conditions. These compounds also showed selective and concentration- dependent
radiosensitization effects under hypoxic conditions.
Conclusion: Tethered compounds 7–9 compared to 5-FU 5 showed minimal cytotoxicities under aerobic and selective
radiosensitizing activities under hypoxic conditions. Also effects of these compounds were higher than those of
metronidazole 1 which is a known cytotoxin and radiosensitizer under hypoxic conditions.
Keywords: Cytotoxicity, Radiosensitizing, Metronidazole, 5-Fluorouracil, MTT& PI-digitonin assaysIntroduction
Oxygen as a radiosensitizer increases the effects of radia-
tion by the formation of free radicals that damage DNA
[1]. Electron affinic nitroaromatic and nitroheterocyclic
compounds act like oxygen by formation of nitro radical
anion through one electron reduction and are solid tumor
targeting agents because of the presence of hypoxic cells
in these tumors due to insufficient blood supply [2].
The cytotoxicity of these compounds under hypoxia has
also been attributed to an increase in the oxidative
damage of DNA, formation of hydroxyl compounds under
deoxygenated conditions, and suppression of intracellular* Correspondence: akhalaj@tums.ac.ir
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reproduction in any medium, provided the orradioprotectors of sulfhydryl compounds [3]. Under aerobic
conditions where the initially reduced species can be readily
re-oxidized by molecular oxygen, the cytotoxicity of
these compounds has been attributed to the parent nitro
compounds, or bio-activation by NADPH: quinine oxido-
reductase (DT diaphorase) which can act as an oxygen
insensitive reductase [4].
Nitroimidazoles [1,2] specifically 2- and 5-nitro derivatives
are known as cytotoxin and radiosensitizer toward hy-
poxic cells and have been subject of many clinical stud-
ies. However these compounds have shown limited
therapeutic impact on radiotherapy due to clinical prob-
lems that includes dose-limiting side effects such as
neurotoxicity [5]. Additionally several hybrid or dual func-
tional agents have been described in which nitroimida-
zoles are attached through a linker unit to cytotoxic
nitrogen mustards, [1,2,6] and aziridine moietiesd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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hanced radiosensitizing activity than those of the corre-
sponding counterparts in both aerobic and hypoxic
cells. In these compounds cellular reduction of the ni-
tro group to more electron donating species activate
the nitrogen of the cytotoxic group by the release of
electron through the aromatic ring and generate react-
ive alkylating species [7].
Previously, results of our study on in vitro aerobic
cytotoxicity of 2, 4-dinitrophenylamine tethered 5-FU
through three carbon atoms in HT-29 cell line with and
without radiation showed that the compound unlike its
components has no cytotoxicity but is radiosensitizer [8].
Since in the tested compound 5-FU is not a leaving group,
it was reasoned that the aerobic cytotoxicity of the reported
2,4-dinitrophenylamine mustard [6] and 2,4-dinitrophenyl
aziridine [7] are due to their alkylating moieties.
Also results of our investigations on 2,4-dinitrobenzyl,
2,4-dinitrobenzoyl, 3,5-dinitrobenzoyl and 2,4-dinitrophen-
acetyl derivatives of 5-FU showed that with exception
of 3,5-dinitrobenzoyl derivatives other compounds have
selective- cytotoxicity and radiosensitization effects under
hypoxic conditions [9]. Since the IC50 values of compounds
which showed selective cytotoxicity were not different sig-
nificantly it was concluded that they have similar mechanism
of action and might produce the same reactive species [9].
In continuation of our investigations on this type of
bifunctional compounds [8-11] in the present study the
cytotoxicity and radiosensitization effects of three novel an-
alogues of these compounds by replacing 2,4-dinitrophenyl
moiety with 2-methyl-5-nitroimidazole (metronidazole),
a known radiosensitizer and cytotoxic agent [2,12] was in-
vestigated. This manuscript describes cytotoxicities and
radiosensitizing activities of metronidazole tethered 5-FU
through ethyl and labile ester groups which was hypothe-
sized upon in vivo hydrolysis to generate active metabolites
which might have synergistic actions.
Materials and methods
Chemistry
Metronidazole 1, 5-FU 5, di-t-butoxydicarbonate (Boc)2O,
triethylamine, sodium hydride and other chemicals and
solvents not listed here were from Merck Chemical Co.
(Merck, Germany). Thin layer chromatography was carried
out using Kieselge l60, 230–400 mesh, (Merck, Germany)
to monitor the progress of reactions. Melting points were
determined on a MEL-270 Sibata melting point apparatus
and are uncorrected. 1HNMR spectra were recorded on
500 MHz a Bruker (Germany), using DMSO-d6 or CDCl3
as solvent. Chemical shifts (δ) are reported in ppm relative
to TMS as internal standard. Mass spectra were obtained
on a Finningan TSQ-70 (USA) instrument. Infrared spectra
were recorded on a Nicolet Magna IR-550 (USA) spec-
trometer. All compounds were characterized by the abovetechniques. Analytical and spectroscopic data for the
known compounds were consistent with the reported




To a solution of metronidazole 1 (3.9 g, 24 mmol) in
100 ml of anhydrous dichloromethane was added 1.9 ml
(24 mmol) triethylamine at temperature below 5°C and
after stirring for 30 min the solution was treated with
3.2 ml (40 mmol) of chloroacetyl chloride dropwise within
5 min and then the resulting solution was stirred at room
temperature overnight. The mixture was filtered and the
residue after evaporation of the solvent was subjected to
flash chromatography using Pet-ether: EtOAC as eluting
solvent (80:20) to give 7.9 g (64%) of the compound 3. mp
80-82°C; 1H NMR (DMSO-d6): δ 8.01 (s, 1H-imidazole),
4.61 (t, J = 5.12 Hz, 2H, CH2-O), 4.48 (t, J = 5.12Hz, 2H,
CH2-N), 4.35 (s, 2H, CH2-Cl), 2.18 (s, 3H, CH3); FT-IR




The reaction of metronidazole 1 (3.9 g, 24 mmol) with
3.85 ml (40 mmol) of 3-chloropropionyl chloride under
above conditions for the preparation of the ester 3 but
purification of the product by crystallization from Pet-ether:
EtOAC instead of flash chromatography gave 4.1 g (71%)
of the ester 4. mp 89-93°C;1H NMR (DMSO-d6): δ 8.01
(s, 1H-imidazole), 4.58 (t, J = 5.10 Hz, 2H, CH2-O), 4.40
(t, J = 5.10 Hz, 2H, CH2-N), 3.7 (t, J = 5.3 Hz, 2H, CH2-Cl),
2.5 (t, J = 5.3 Hz, 2H, CH2-C = O), 2.18 (s, 3H, CH3);
FT-IR (KBr): 1729 (C = O), 1540, 1345 (NO2) cm
-1.
General procedure for the synthesis of tethered
compounds 7–9
To a stirred solution of 225 mg (1 mmol) of 1-(t-butoxycar-
bonyl)-5-FU 6 [13] in 10 ml of anhydrous DMF in a round
bottom flask which was kept in an ice bath was added 30
mg (1.25 mmol) of sodium hydride within 10 min and after
stirring for 30 min at 5°C the mixture was then treated with
a solution of 1 mmol of metronidazole esters 2-4 in 10 ml
of anhydrous DMF and the mixture stirred at room
temperature for 18 h. The mixture was then diluted with
the same volume of water, extracted with ethyl acetate
(3×20 ml), and the organic layer was dehydrated using an-
hydrous sodium sulfate. Evaporation of ethyl acetate gave
an oily residue which was dissolved in 10 ml of methanol,
treated with 0.42 g potassium carbonate and the obtained
mixture was stirred at room temperature for 1 h. After
evaporation of the solvent under reduced pressure, the
residue was dissolved in water-ethyl acetate mixture
(1:1), the organic layer was separated and dehydrated
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reduced pressure. For the preparation of compound 7, the
residue after evaporation of the solvent was purified by
flash chromatography using Pet-ether: EtOAC as eluting
solvent (70:30) to give 100 mg (35%) of the product. For
the preparation of compounds 8 and 9, residues were
crystallized from Hexan-EtOAC to give 310 mg (92%) and
330 mg (93%) of the pure products respectively.5-fluoro-3-(2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl)
pyrimidine-2,4(1H,3H)-dione(7)
mp 185-189°C; 1HNMR (CDCl3): δ 7.9 (s, 1H-imidazol),
7.8 (d, 1H, CH=CF), 4.0 (t, CH2), 3.9 (t, CH2), 2.4 (s, 3H,
CH3); FT-IR (KBr): 3108 (NH), 1722, 1671 (C =O), 1550,
1350 (NO2) cm
-1; MS: m/z 81(100%), 130 (78%), 238
(39%), 155(24%).2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl 2-(5-fluoro-2,6-
dioxo-2,3-dihydropyrimidin-1(6H)-yl)-acetate(8)
mp 231–234°C; 1H NMR (DMSO-d6): δ 7.99 (s, 1H-
imidazole), 7.93 (d, J = 8.5 Hz, 1H, CH = CF), 4.65 (t, J =
5.02 Hz, 2H, CH2-O), 4.42 (s, 2H, CH2-C = O), 3.98
(t, J = 5.02 Hz, 2H, CH2-N), 2.42 (s, CH3); FT-IR (KBr):
3131 (NH), 1725, 1656 (C = O), 1542, 1349 (NO2) cm
-1;
MS: m/z 341 (7%), 296 (23%), 212 (80%), 171(74%), 130
(100%), 126 (42%).Scheme 1 Reagent and conditions for the synthesis of compounds 7–
(iv) DMF, NaH, 80°C, (v) CH3OH, K2CO3.2-(2-methyl-5-nitro-1H-imidazol-1-yl) ethyl 2-(5-fluoro-2,6-
dioxo-2,3-dihydropyrimidin-1(6H)-yl)-propanoate(9)
mp 247-250°C; 1H NMR (DMSO-d6): δ 8.01 (s, 1H-
imidazole), 7.98 (d, J = 8.5Hz, 1H, CH = CF), 4.57 (t, J =
5.05 Hz, 2H, CH2-O), 4.39 (t, J = 5.05 Hz, 2H, CH2-N),
3.78 (t, J = 6.8 Hz, 2H, CH2-N), 2.70 (t, J = 6.8 Hz, 2H,
CH2-C = O), 2.44 (s, CH3); FT-IR (KBr): 3124 (NH),
1721, 1652 (C =O), 1547, 1350 (NO2) cm
-1; MS: m/z
355 (5%), 309 (21%), 226 (86%), 185(75%), 171 (42%),
130 (100%), 126 (59%).In vitro cytotoxicity
Materials HT-29 cells, originally derived from human
colorectal carcinoma were obtained from Pasteur Institute
(Tehran, Iran). Fetal Bovine Serum (FBS), Penicillin/
Streptomycin 100X, Trypsin-EDTA 10X and Trypan blue
were from Biosera (England). RPMI 1640 from Gibco
(England), MTT and PI from Sigma (USA) and Digitonin
from Merck (Germany) were used in this study.Cell culture HT-29 cells were grown as an attached
monolayer in RPMI 1640 supplemented with 10% fetal
bovine serum, penicillin (50 unit/ml), and streptomycin
(50 μg/ml). Cells were routinely grown in tissue culture
flasks and kept in a humidified atmosphere of 5% CO2
and 95% air at 37°C [14].9. (i) Pyridine <15°C, (ii) CH2Cl2, triethylamine, r. t, (iii) 4-DMAP/CH3CN,
Figure 1 Clonogenic survival of incubation of HT-29 cell line
with different concentration of compound 7 after 3 h (A) and
48 h (B) under aerobic (•) and hypoxic (▲) conditions. Data
points were obtained from three independent experiments, and the
standard deviations are given for each point. (Mean ± SD each set
of experiments was performed in triplicates).
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Cytotoxicity of 5-FU5, metronidazole 1, and tethered
compounds 7–9 against HT-29 cells under both aerobic
and hypoxic conditions were determined by measurement
of the percentage of cell survivals using MTT [15] and
PI-digitonin [16,17] and clonogenic forming assays [18].
Cells were seeded at the density of 104 cells/well in 96-well
culture dishes and incubated for 4 h. Stock solutions of the
tested compounds in DMSO at concentrations of 50 mmol
which were prepared prior to the experiments diluted with
culture media and at concentrations of 6.25-400 μmol/ml
added to each well of plates. Cells in the control wells were
treated with the same volume of medium which contained
DMSO at concentration equal to those which were used
in incubations treated with the tested compounds. Cell
incubations were kept at 37°C under either air by purging
with 95% nitrogen and 5% CO2 or hypoxia in sealed
GasPack jar by using Anoximat (Netherland) and an anaer-
obic chamber GasPak Jar (Merck, Germany) and GasPak
pluss (Merck, Germany) [19] for 3 or 48 h. After removal
of the supernatant of the culture medium, wells were
washed with phosphate buffer saline (PBS), and the num-
bers of live cells were determined by following methods.
MTT assay
25 μl of the reagent (5 mg/ml in PBS) was added to each
well, cell cultures were incubated for 4 h at 37°C and then
the precipitated formazan was dissolved in 100 μl of DMSO
and its absorbance was read in Elisa reader at 550 nm and
a background wavelength of 690 nm. Survival was scored
by the ratio of the absorbance of the treated cells to
untreated cells with the tested compounds (control) and is
expressed as percentage of the cell survival [15].
PI-digitonine assay
20 μl of a 1.53 mmol solution of PI in PBS for a final
concentration of 30 μmol was added to each well, cell
cultures were incubated for 60 min at 37°C and then the
initial fluorescence intensity from the dead cells was mea-
sured in a multi-well plate reader, (BioTek, Synergy HT,
USA) with 530-nm excitation and 645-nm emission filters.
Then digitonin (600 nmol) was added to each well to
permeabilize all cells and label all nuclei with PI and
after 30 min incubation, the fluorescence intensity was
measured again to obtain a value corresponding to the
total number of cells. The percentage of dead cells was
calculated as the proportion of fluorescence intensity
of the dead cells to that of total cells multiplied by 100
and percentage of the cell viability was calculated by sub-
tracting the percentage of dead cells from 100% [16].
The IC50 values for both MTT and PI-digitonine assays
were determined from cell survival curves in which the
percentages of cells that survived were plotted as a function
of the concentration of the tested compounds.Clonogenic forming assay
The medium of the cell cultures after treatment
with the tested compounds and/or irradiation under
aerobic or hypoxic conditions were first separated to
remove the tested compounds, and washed with PBS.
Cells were seeded in 6-well plates at concentration
of 5 × 103 cells per well and maintained at 37°C for
14 days. The cells were then fixed in methanol, col-
onies which were formed stained with crystal violet
and those containing more than 50 cells were scored.
The number of colonies of treated and untreated
dishes with the tested compounds were compared
and expressed as the percentage of survival by clono-
genic assay [18]. Clonogenic survival curves were
constructed by plotting percent of survivals in
response to different concentrations of the tested
compounds.
Table 1 Cytotoxicity and radiosensitization of metronidazole 1, 5-fluorouracil 5, and tethered compounds 7-9
IC50 (μmole) SER
Compound MTT assaya PI assayb Concentration (μmole)
25 50 100
Aerobic Hypoxic Aerobic Hypoxic Aerobic Hypoxic Aerobic Hypoxic Aerobic Hypoxic
1 338 ± 12 265.9 ± 19 311 ± 16 250 ± 23 1.07 ± 0.06 1.26 ± 0.02 1.15 ± 0.09 1.69 ± 0.08 1.27 ± 0.02 2.06 ± 0.06
5 93 ± 9 89 ± 7 88 ± 7 84 ± 5 1.09 ± 0.06 1.04 ± 0.04 1.12 ± 0.09 1.18 ± 0.11 1.16 ± 0.11 1.12 ± 0.06
7 330 ± 16 240 ± 14 318 ± 20 230 ± 11 1.11 ± 0.11 1.41 ± 0.06 1.19 ± 0.05 1.85 ± 0.05 1.25 ± 0.010 2.17 ± 0.11
8 309 ± 25 232.1 ± 21 296 ± 18 229 ± 19 1.07 ± 0.03 1.51 ± 0.12 1.13 ± 0.08 1.95 ± 0.12 1.31 ± 0.12 2.26 ± 0.16
9 304 ± 18 234 ± 11 299 ± 14 224 ± 25 1.13 ± 0.06 1.43 ± 0.07 1.22 ± 0.10 1.79 ± 0.05 1.33 ± 0.05 2.13 ± 0.08
a3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.
bPropidium Iodide-Digitonin assay.
Figure 2 Clonogenic cell survival of HT-29 cells under aerobic
conditions, (A): upon exposure to 4 Gy gamma-irradiation after
incubation with different concentration (25, 50, 100 μmole) of
metronidazole 1 and tethered compounds 7–9 for 3 h, (B): upon
exposure to different doses (2, 4, 8 and 12 Gy) of radiation after
incubation with 50 μmol of metronidazole 1 and tethered com-
pounds 7–9 for 3 h. Each data points were obtained from three
independent experiments, and the standard deviations are given for
each point. (Mean ± SD).
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Irradiation
HT-29 cells at 37°C under hypoxic or aerobic conditions
were incubated with the tested compounds at concentra-
tions of 25, 50, and 100 μmol for 3 h and then at room
temperature were exposed to 4 different doses of radiation
(2, 4, 8 and 12 Gy) at the dose rate of 1.67 Gy/min and
Source Surface Distance (SSD) = 80 cm2 by a 60Co source
(Theratron 780 MDS – Nordion).
Radiosensitivity measurement
Radiosensitivity of the tested compounds were determined
through measurement of the cell growth inhibition using
clonogenic assay [18]. Results are presented in terms of
Sensitization Enhancement Ratio (SER) which were calcu-
lated from the equation SER = Do untreated cells/ Do
treated cells, where Do values represent radiation dose that
leads to 37% cell survival [20]. Do values were obtained
from the survival curves of irradiation in the presence and
absence of the tested compounds.
Statistical analyses
For the cell survival and cell death assays each experiment
was repeated three times and results are mean ± SD of
three independent experiments. Statistical analysis was
performed using Sigmaplot 12 (Systat Software Inc.) for
window and descriptive statistics are shown as arithmetic
mean ± standard deviation. Independent samples’ t-test
was used to investigate the mean differences between
irradiated and un-irradiated cells treated with the tested
compounds and for comparison of more than two groups,
Holm-Sidak multiple comparison test followed by one way
analysis of variance (One way ANOVA) were performed
and p value smaller than 0.05 was considered statistically
significant.
Results and discussion
Tethered compounds 7–9 were prepared by the reaction
of 1-(t-butoxycarbonyl)-5-FU 6 [13] with p-toluenesulfonic,
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nidazole 1 (compounds 2–4, Scheme 1) respectively in DMF
in the presence of sodium hydride followed by removal of
t-butoxycarbonyl group in methanolic potassium carbo-
nate. Esters 3, 4 were obtained by the reported method
for the preparation of the ester 2 [21] through the reaction
of metronidazole 1 with 2-chloroacetyl chloride, and 3-
chloropropionyl chloride respectively in pyridine.
Effects of different concentrations of 5FU 5, metronida-
zole 1, and tethered compounds 7–9 for different incuba-
tion periods on viability and proliferation of HT-29 cells
were determined by MTT (15), PI-digitonin [16,17], and
clonogenic assays (18). The tested compounds inhibited
HT-29 cell proliferation in a time dependent manner and
as it is shown for the compound 7 (Figure 1A) cell survival
at 3 h after incubation were similar (p > 0.05) but after
48 h were significantly different (p < 0.05). IC50 values were
assessed from cell survival curves in which the percentage
of cells that survived after 48 h incubation were plotted as
a function of the concentration of tested compounds
(Table 1). Results of this study showed that IC50 values
of each compound for the cell survival under aerobic
or hypoxic conditions determined either by MTT or by
PI-digitonin assays are not different significantly (p > 0.05)
from each other and results of these tests which are
seldom unanimous [12] were in good agreement.Figure 3 Clonogenic cell survival of HT-29 cells upon exposure to diff
incubation for 3 h with different concentrations (0, 25, 50 and 100 μm
hypoxic conditions. Data points were obtained from three independent e
(Mean ± SD, each set of experiments was performed in triplicates).While tethered compounds 7–9 under hypoxic conditions
exhibited remarkable concentration–dependent cytotoxicity
(Figure 1B), these compounds under aerobic conditions
were not or were slightly cytotoxic whereas at concentra-
tions up to 100 μmol could reduce viabilities of HT-29
cells only to less than 10% (Figure 1B). Consistent with
these results the IC50 values of these compounds were sig-
nificantly lower (p <0.05) under hypoxic (232.1±21-240±14)
compared to aerobic (304±18-330±16) conditions sugges-
ting that compounds have hypoxia-selective cytotoxicity.
The radiosensitizing activities of all tested compounds
were determined by measurement of the cell growth inhi-
bition using a standard colony formation method following
exposure of incubations with different concentrations
of the tested compounds to different doses of the radiation
[18]. Results are presented in term of Sensitization En-
hancement Ratio (SER) which were obtained from the sur-
vival curves of irradiation in the presence and absence of
the tested compounds for 37% survival respectively (20).
The radiosensitization effects of compounds 7–9 at vari-
ous concentrations under aerobic conditions were not dif-
ferent significantly (p > 0.05) (Figure 2A) and at a given
concentration only increase in the dose of radiation re-
sulted in decrease in the cell survival (Figure 2B). However
under hypoxic conditions (Figures 3) radiosensitization
effects of these compounds increased significantly witherent doses of Gamma-radiation (2, 4, 6, 8 and 12 Gy) after
ole) of metronidazole 1 and tethered compounds 7–9 under
xperiments, and the standard deviations are given for each point.
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diation ( p < 0.05) These results were further supported by
their SER values (Table 1) which under hypoxic conditions
were concentration- dependent and relative to aerobic
conditions were significantly higher (p < 0.05). The SER
values of tethered compound 7–9 under aerobic condi-
tions at all concentrations were lower and under hypoxic
conditions at concentrations of 50 and 100 μmol were
higher than 1.6 which is the minimum required value [22]
for an in vitro radiosensitizing activity, indicating that
these compounds have hypoxia-selective radiosensitiza-
tion effects. From the results of this study it appears that
the functional groups and the length of the linker chain
have no contribution on in vitro effects of tethered
compounds 7–9 since cytotoxities and radiosensitizing
activities of these compounds under either hypoxic or
aerobic conditions were not significantly different from
each other.
Conclusion
While the cytotoxicity of 5-FU 5 against HT-29 cell line
under aerobic and hypoxic conditions were not different
significantly and this compound at all concentrations
showed no radiosensitizing activity, tethered compounds
7–9 showed higher cytotoxicities and selective radiosen-
sitizing activities under hypoxic conditions. Also effects
of these compounds relative to metronidazole 1 which is
a known cytotoxin and radiosensitizer were comparable
under aerobic but higher under hypoxic conditions. Further
exploration of these compounds through modification of
the linker chain might result in compounds which their
uses in conjunction with tumor radiotherapy have greater
toxicity to tumor than normal tissues.
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